Pujana M A, Volpini V, Gratacós M, Corral J, Banchs I, Sánchez A, Genís D, Cervera C, Estivill X
Molecular Genetics Department, Medical and Molecular Genetics Centre-IRO, Hospital Duran i Reynals, Barcelona, Spain.
J Med Genet. 1998 Feb;35(2):99-102. doi: 10.1136/jmg.35.2.99.
In some neurodegenerative diseases, genetic anticipation correlates with expansions of the CAG/CTG repeat sequence above the normal range through the generations of a pedigree. Among these neurodegenerative diseases are late onset autosomal dominant cerebellar ataxias (ADCA). ADCA are genetically heterogeneous disorders with different cloned genes for spinocerebellar ataxia type 1 (SCA1), type 2 (SCA2), type 3 or Machado-Joseph disease (SCA3/MJD), and type 6 (SCA6). Another related dominant ataxia, dentatorubral-pallidoluysian atrophy (DRPLA), also shows CAG/CTG repeat expansions. Genetic anticipation has been reported for all of them except for the recently cloned SCA6 gene. Other, as yet undetected SCA genes may show the same features. We have used the repeat expansion detection (RED) method to detect repeat expansions directly in DNA samples from ADCA patients not resulting from known genes. Our sample consists of 19 affected index cases, corresponding to 52.8% of our ADCA families without CAG/CTG repeat expansions in the SCA1, SCA2, SCA3/MJD, SCA6, or DRPLA genes. Eighty-nine percent of the index cases had expansions of a CAG/CTG sequence greater than 40 repeats by RED, while these were observed in only 26.9% of 78 healthy subjects from the general population (p < 0.0001). The distribution of RED fragments in controls and ADCA patients also shows significant differences with the Mann-Whitney U test (U = 376.5, p = 0.0007). Moreover, there was a significant inverse correlation between the size of expansion and the age of onset (r = -0.54, p = 0.018). These results show CAG/CTG repeat expansions of over 40 repeats in our sample of ADCA families not resulting from known SCA genes.
在一些神经退行性疾病中,遗传早现现象与家系中几代人CAG/CTG重复序列在正常范围之上的扩增相关。这些神经退行性疾病包括迟发性常染色体显性小脑共济失调(ADCA)。ADCA是具有遗传异质性的疾病,其脊髓小脑共济失调1型(SCA1)、2型(SCA2)、3型或马查多-约瑟夫病(SCA3/MJD)以及6型(SCA6)有不同的克隆基因。另一种相关的显性共济失调,齿状核红核苍白球路易体萎缩症(DRPLA),也显示出CAG/CTG重复序列扩增。除了最近克隆的SCA6基因外,所有这些疾病都有遗传早现的报道。其他尚未检测到的SCA基因可能也具有相同的特征。我们使用重复序列扩增检测(RED)方法直接在来自ADCA患者的DNA样本中检测重复序列扩增,这些患者并非由已知基因导致。我们的样本包括19例受累的索引病例,占我们SCA1、SCA2、SCA3/MJD、SCA6或DRPLA基因中无CAG/CTG重复序列扩增的ADCA家系的52.8%。通过RED检测,89%的索引病例CAG/CTG序列扩增超过40次重复,而在来自普通人群的78名健康受试者中仅26.9%观察到这种情况(p<0.0001)。对照组和ADCA患者中RED片段的分布经曼-惠特尼U检验也显示出显著差异(U = 376.5,p = 0.0007)。此外,扩增大小与发病年龄之间存在显著的负相关(r = -0.54,p = 0.018)。这些结果表明,在我们的非已知SCA基因导致的ADCA家系样本中存在超过40次重复的CAG/CTG重复序列扩增。